ABVC BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fremont, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ABVC BIOPHARMA, INC. has filed 781 SEC EDGAR filings since 28 Jun 2002

SEC filing history

Showing 126-150 of 570 matching filings.

Per page
25
Current page
6
UPLOAD File 333-276500

UPLOAD filing

Filing date
22 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-40700

AMENDMENT NO. 1 TO FORM 8-K

Filing date
17 Jan 2024
Reporting date
20 Nov 2023
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
17 Jan 2024
Reporting date
16 Jan 2024
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
17 Jan 2024
Reporting date
17 Jan 2024
Next action
Verify source filing
S-1 File 333-276500

REGISTRATION STATEMENT

Filing date
12 Jan 2024
Reporting date
Not listed
Next action
Verify source filing
DEF 14A File 001-40700

PROXY STATEMENT

Filing date
29 Dec 2023
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40700

PROXY STATEMENT

Filing date
15 Dec 2023
Reporting date
15 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
20 Nov 2023
Reporting date
20 Nov 2023
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS SUPPLEMENT

Filing date
17 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-271416

PROSPECTUS SUPPLEMENT

Filing date
17 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255112

PROSPECTUS SUPPLEMENT

Filing date
17 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
16 Nov 2023
Reporting date
16 Nov 2023
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
15 Nov 2023
Reporting date
15 Nov 2023
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
15 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
NT 10-Q File 001-40700

NOTIFICATION OF LATE FILING

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
13 Sep 2023
Reporting date
13 Sep 2023
Next action
Verify source filing
8-K/A File 001-40700

AMENDMENT NO. 1 TO FORM 8-K

Filing date
06 Sep 2023
Reporting date
17 Aug 2023
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
31 Aug 2023
Reporting date
31 Aug 2023
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS SUPPLEMENT NO. 2 DATED AUGUST 16, 2023.

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-271416

PROSPECTUS SUPPLEMENT NO. 1 DATED AUGUST 16, 2023.

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255112

PROSPECTUS SUPPLEMENT NO. 2 DATED AUGUST 16, 2023.

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
17 Aug 2023
Reporting date
14 Aug 2023
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
8-K/A File 001-40700

AMENDMENT NO. 1 TO FORM 8-K

Filing date
09 Aug 2023
Reporting date
22 Aug 2022
Next action
Verify source filing
SC 13G File 005-84759

SC 13G filing

Filing date
07 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .